SRRK Return on Tangible Equity | SCHOLAR ROCK HOLDING CORPORATION

SCHOLAR ROCK HOLDING CORPORATION (SRRK) Return on Tangible Equity

2026-06-30: Return Tang Equity -161.00%.
2026-03-31: Return Tang Equity -148.08%.
2025-12-31: Return Tang Equity -153.95%.
2025-09-30: Return Tang Equity -144.26%.

Complete source-backed return tang equity history.

Available history: 2017-12-31 to 2026-06-30
Data captured: 2026-09-04

Historical Return Tang Equity

Date	Return Tang Equity
2026-06-30	-161.00%
2026-03-31	-148.08%
2025-12-31	-153.95%
2025-09-30	-144.26%
2025-06-30	-135.32%
2025-03-31	-84.58%
2024-12-31	-66.81%
2024-09-30	-285.33%
2024-06-30	-152.56%
2024-03-31	-100.27%
2023-12-31	-73.61%
2023-09-30	-94.78%
2023-06-30	-78.94%
2023-03-31	-72.57%
2022-12-31	-51.68%
2022-09-30	-44.72%
2022-06-30	-38.05%
2022-03-31	-65.42%
2021-12-31	-76.59%
2021-09-30	-65.39%
2021-06-30	-50.08%
2021-03-31	-40.36%
2020-12-31	-33.16%
2020-09-30	-113.51%
2020-06-30	-77.97%
2020-03-31	-58.10%
2019-12-31	-45.17%
2019-09-30	-44.66%
2019-06-30	-38.00%
2019-03-31	-52.49%
2018-12-31	-46.26%
2018-09-30	-41.84%
2018-06-30	-34.03%
2018-03-31	47.08%

Annual Return Tang Equity

Date	Return Tang Equity
2025-12-31	-153.95%
2024-12-31	-66.81%
2023-12-31	-73.61%
2022-12-31	-51.68%
2021-12-31	-76.59%
2020-12-31	-33.16%
2019-12-31	-45.17%
2018-12-31	-46.26%
2017-12-31	46.70%

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
CG Oncology, Inc. (CGON)	United States	$6.095B	-27.95
CRISPR Therapeutics AG (CRSP)		$5.390B	-11.68
IOVANCE BIOTHERAPEUTICS, INC. (IOVA)	United States	$4.897B	-6.51
Immunovant, Inc. (IMVT)	United States	$7.028B	-14.78
Adaptive Biotechnologies Corp (ADPT)	United States	$4.719B	-53.43
Relay Therapeutics, Inc. (RLAY)	United States	$3.884B	-14.30
Vaxcyte, Inc. (PCVX)	United States	$8.466B	-7.91
Tarsus Pharmaceuticals, Inc. (TARS)	United States	$3.329B	-58.60
Denali Therapeutics Inc. (DNLI)	United States	$3.274B	-8.04
ImmunityBio, Inc. (IBRX)	United States	$9.157B	-9.29